subject: UMLS:C0006055


subject: UMLS:C0006055

subject_name: Botulinum Toxins

object_name: Thumb sprain

tested_intervention: unsure


subject: CHEBI:36021

subject_name: octadec-9-enoic acid

object_name: type 2 diabetes mellitus


subject: CHEBI:36021

object_name: Diabetes


subject: CHEBI:36021

object_name: diabetes mellitus


subject: CHEBI:36021

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:36021

object_name: obesity


subject: CHEBI:36021

object_name: Obesity, CTCAE


subject: CHEBI:36021

object_name: hyperlipidemia


subject: CHEBI:36021

object_name: hyperlipoproteinemia


subject: CHEBI:36021

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:36021

object_name: Serum lipids high (finding)


subject: CHEBI:16196

subject_name: oleic acid


subject: CHEBI:16196


subject: CHEBI:16196


subject: CHEBI:16196


subject: CHEBI:16196


subject: CHEBI:16196


subject: CHEBI:16196


subject: CHEBI:16196


subject: CHEBI:16196


subject: CHEBI:16196


subject: CHEBI:37659

subject_name: oleanolic acid


subject: CHEBI:37659


subject: CHEBI:37659


subject: CHEBI:37659


subject: CHEBI:37659


subject: CHEBI:37659


subject: CHEBI:37659


subject: CHEBI:37659


subject: CHEBI:37659


subject: CHEBI:37659


subject: CHEBI:138856

subject_name: Oxolinic acid


subject: CHEBI:138856


subject: CHEBI:138856


subject: CHEBI:138856


subject: CHEBI:138856


subject: CHEBI:138856


subject: CHEBI:138856


subject: CHEBI:138856


subject: CHEBI:138856


subject: CHEBI:138856


subject: UNII:5792C4VMFZ

subject_name: Calcium palmitate


subject: UNII:5792C4VMFZ


subject: UNII:5792C4VMFZ


subject: UNII:5792C4VMFZ


subject: UNII:5792C4VMFZ


subject: UNII:5792C4VMFZ


subject: UNII:5792C4VMFZ


subject: UNII:5792C4VMFZ


subject: UNII:5792C4VMFZ


subject: UNII:5792C4VMFZ


subject: CHEBI:15756

subject_name: Palmitic Acid


subject: CHEBI:15756


subject: CHEBI:15756


subject: CHEBI:15756


subject: CHEBI:15756


subject: CHEBI:15756


subject: CHEBI:15756


subject: CHEBI:15756


subject: CHEBI:15756


subject: CHEBI:15756


subject: CHEBI:32019

subject_name: Piromidic acid


subject: CHEBI:32019


subject: CHEBI:32019


subject: CHEBI:32019


subject: CHEBI:32019


subject: CHEBI:32019


subject: CHEBI:32019


subject: CHEBI:32019


subject: CHEBI:32019


subject: CHEBI:32019


subject: CHEBI:133659

subject_name: Pro-Ala


subject: CHEBI:133659


subject: CHEBI:133659


subject: CHEBI:133659


subject: CHEBI:133659


subject: CHEBI:133659


subject: CHEBI:133659


subject: CHEBI:133659


subject: CHEBI:133659


subject: CHEBI:133659


subject: CHEBI:33386

subject_name: Protactinium


subject: CHEBI:33386


subject: CHEBI:33386


subject: CHEBI:33386


subject: CHEBI:33386


subject: CHEBI:33386


subject: CHEBI:33386


subject: CHEBI:33386


subject: CHEBI:33386


subject: CHEBI:33386


subject: CHEBI:30745

subject_name: Phenylacetic acid


subject: CHEBI:30745


subject: CHEBI:30745


subject: CHEBI:30745


subject: CHEBI:30745


subject: CHEBI:30745


subject: CHEBI:30745


subject: CHEBI:30745


subject: CHEBI:30745


subject: CHEBI:30745


subject: CHEBI:8428

subject_name: Procainamide


subject: CHEBI:8428


subject: CHEBI:8428


subject: CHEBI:8428


subject: CHEBI:8428


subject: CHEBI:8428


subject: CHEBI:8428


subject: CHEBI:8428


subject: CHEBI:8428


subject: CHEBI:8428


subject: CHEBI:7959

subject_name: Penicillamine


subject: CHEBI:7959


subject: CHEBI:7959


subject: CHEBI:7959


subject: CHEBI:7959


subject: CHEBI:7959


subject: CHEBI:7959


subject: CHEBI:7959


subject: CHEBI:7959


subject: CHEBI:7959


subject: CHEBI:16335

subject_name: Adenosine


subject: CHEBI:16335


subject: CHEBI:16335


subject: CHEBI:16335


subject: CHEBI:16335


subject: CHEBI:16335


subject: CHEBI:16335


subject: CHEBI:16335


subject: CHEBI:16335


subject: CHEBI:16335


subject: CHEBI:30768

subject_name: Propanoic acid


subject: CHEBI:30768


subject: CHEBI:30768


subject: CHEBI:30768


subject: CHEBI:30768


subject: CHEBI:30768


subject: CHEBI:30768


subject: CHEBI:30768


subject: CHEBI:30768


subject: CHEBI:30768


subject: PR:000049747

subject_name: influenzavirus PA gene translation product


subject: PR:000049747


subject: PR:000049747


subject: PR:000049747


subject: PR:000049747


subject: PR:000049747


subject: PR:000049747


subject: PR:000049747


subject: PR:000049747


subject: PR:000049747


subject: PR:000004008

subject_name: alpha-amylase 2A


subject: PR:000004008


subject: PR:000004008


subject: PR:000004008


subject: PR:000004008


subject: PR:000004008


subject: PR:000004008


subject: PR:000004008


subject: PR:000004008


subject: PR:000004008


subject: PR:000012849

subject_name: biogenesis of lysosome-related organelles complex 1 subunit 6


subject: PR:000012849


subject: PR:000012849


subject: PR:000012849


subject: PR:000012849


subject: PR:000012849


subject: PR:000012849


subject: PR:000012849


subject: PR:000012849


subject: PR:000012849


subject: PR:000013209

subject_name: salivary acidic proline-rich phosphoprotein


subject: PR:000013209


subject: PR:000013209


subject: PR:000013209


subject: PR:000013209


subject: PR:000013209


subject: PR:000013209


subject: PR:000013209


subject: PR:000013209


subject: PR:000013209


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage IIIC Cutaneous Melanoma AJCC v7

tested_intervention: yes


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C0042210

subject_name: Vaccines

object_name: respiratory syncytial virus infectious disease


subject: UMLS:C0042210

object_name: Premature Labor


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Renal transplant rejection


subject: CHEBI:6121

subject_name: Ketamine

object_name: Hypoventilation


subject: UMLS:C2349000

subject_name: Human Papillomavirus Vaccine V503

object_name: cervical cancer


subject: UMLS:C2349000

object_name: vaginal cancer


subject: UMLS:C2349000

object_name: vaginal carcinoma


subject: UMLS:C2349000

object_name: Lesion of genitalia


subject: UMLS:C2349000

object_name: vulva cancer


subject: UMLS:C2349000

object_name: vulva carcinoma


subject: CHEBI:76607

subject_name: Macitentan

object_name: sickle cell disease


subject: PUBCHEM.COMPOUND:66586232

object_name: mucositis


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: cholangitis


subject: CHEBI:29007

subject_name: Ceftriaxone


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA

object_name: stroke disorder


subject: UNII:XRO4566Q4R

object_name: cerebrovascular disorder


subject: UMLS:C0594372

subject_name: Avonex


subject: UMLS:C0594372


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Malignant neoplasm of female breast


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: rheumatoid arthritis


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Prostate cancer recurrent


subject: CHEBI:49603

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:49603

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:49603

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:49603

object_name: Stage IV Prostate Cancer AJCC v8


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: short bowel syndrome


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: CHEBI:50653

subject_name: Sizofiran

object_name: cervical cancer


subject: CHEBI:50653

object_name: cervical carcinoma


subject: UMLS:C3536894

subject_name: Sonifilan


subject: UMLS:C3536894


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: Androgen excess


subject: UMLS:C3540792

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C3540792

object_name: obesity


subject: UMLS:C3540792

object_name: Obesity, CTCAE


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: CHEBI:76567

subject_name: polyunsaturated fatty acid anion


subject: UMLS:C0032615

subject_name: Polyunsaturated Fatty Acids


subject: CHEBI:26208

subject_name: polyunsaturated fatty acid


subject: UNII:0P1E1UF04I

subject_name: Penehyclidine hydrochloride

object_name: post operative nausea and vomiting


subject: UMLS:C2606726

object_name: Pelvis fracture


subject: UMLS:C2606726

object_name: Hip Fracture, CTCAE


subject: UMLS:C2606726

object_name: hip fracture


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Hot Flashes, CTCAE


subject: PUBCHEM.COMPOUND:4715169

object_name: Hot flashes


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Rest limb pain


subject: CHEBI:15365

subject_name: Aspirin


subject: UMLS:C1443062

subject_name: Vaccinium myrtillus antigen

object_name: mucositis


subject: UMLS:C1443062

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UMLS:C1443062

object_name: stage IVA squamous cell carcinoma of the larynx


subject: UMLS:C1443062

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C1443062

object_name: stage IVB squamous cell carcinoma of the larynx


subject: UMLS:C1443062

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C1443062

object_name: Laryngeal squamous cell carcinoma stage III


subject: UMLS:C1443062

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C1443062

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C1443062

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: UMLS:C1443062

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UMLS:C1443062

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: UMLS:C1443062

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UMLS:C1443062

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C1443062

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: UMLS:C1443062

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UMLS:C1443062

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C1443062

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: UMLS:C1443062

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: UMLS:C1443062

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UMLS:C1443062

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: UMLS:C1443062

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UMLS:C1443062

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C1443062

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: UMLS:C1443062

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: UMLS:C1443062

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: UMLS:C1443062

object_name: stage III squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UMLS:C1443062

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UMLS:C1443062

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UMLS:C1443062

object_name: Laryngeal verrucous carcinoma recurrent


subject: UMLS:C1443062

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: UMLS:C1443062

object_name: stage IVB verrucous carcinoma of the larynx


subject: UMLS:C1443062

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: UMLS:C1443062

object_name: stage IVA verrucous carcinoma of the larynx


subject: UMLS:C1443062

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: UMLS:C1443062

object_name: Laryngeal verrucous carcinoma stage III


subject: UMLS:C1443062

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: UMLS:C1443062

object_name: Verrucous carcinoma of the oral cavity stage III


subject: UMLS:C1443062

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: UMLS:C1443062

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: UMLS:C1443062

object_name: tongue cancer


subject: UMLS:C1443062

object_name: tongue carcinoma


subject: DRUGBANK:DB14235

subject_name: Bilberry

object_name: mucositis


subject: DRUGBANK:DB14235

object_name: Laryngeal squamous cell carcinoma recurrent


subject: DRUGBANK:DB14235

object_name: stage IVA squamous cell carcinoma of the larynx


subject: DRUGBANK:DB14235

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: DRUGBANK:DB14235

object_name: stage IVB squamous cell carcinoma of the larynx


subject: DRUGBANK:DB14235

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: DRUGBANK:DB14235

object_name: Laryngeal squamous cell carcinoma stage III


subject: DRUGBANK:DB14235

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: DRUGBANK:DB14235

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: DRUGBANK:DB14235

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: DRUGBANK:DB14235

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: DRUGBANK:DB14235

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: DRUGBANK:DB14235

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: DRUGBANK:DB14235

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: DRUGBANK:DB14235

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: DRUGBANK:DB14235

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: DRUGBANK:DB14235

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: DRUGBANK:DB14235

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: DRUGBANK:DB14235

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: DRUGBANK:DB14235

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: DRUGBANK:DB14235

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: DRUGBANK:DB14235

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: DRUGBANK:DB14235

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: DRUGBANK:DB14235

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: DRUGBANK:DB14235

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: DRUGBANK:DB14235

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: DRUGBANK:DB14235

object_name: stage III squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: DRUGBANK:DB14235

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: DRUGBANK:DB14235

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: DRUGBANK:DB14235

object_name: Laryngeal verrucous carcinoma recurrent


subject: DRUGBANK:DB14235

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: DRUGBANK:DB14235

object_name: stage IVB verrucous carcinoma of the larynx


subject: DRUGBANK:DB14235

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: DRUGBANK:DB14235

object_name: stage IVA verrucous carcinoma of the larynx


subject: DRUGBANK:DB14235

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: DRUGBANK:DB14235

object_name: Laryngeal verrucous carcinoma stage III


subject: DRUGBANK:DB14235

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: DRUGBANK:DB14235

object_name: Verrucous carcinoma of the oral cavity stage III


subject: DRUGBANK:DB14235

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: DRUGBANK:DB14235

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: DRUGBANK:DB14235

object_name: tongue cancer


subject: DRUGBANK:DB14235

object_name: tongue carcinoma


subject: CHEBI:60654

subject_name: valproate

object_name: Bedwetting


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:9168

subject_name: Sirolimus

object_name: liver carcinoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: INTELLIGENCE QUANTITATIVE TRAIT LOCUS 1


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH

object_name: brain injury


subject: CHEBI:73757

subject_name: Ala-Gly

object_name: type 2 diabetes mellitus


subject: CHEBI:193565


subject: CHEBI:73836

subject_name: D-Ala-Gly


subject: UMLS:C1370189

subject_name: Pneumocystis jiroveci antigen


subject: CHEBI:27569

subject_name: arabinogalactan


subject: MESH:D019081

subject_name: O Antigens


subject: MESH:D000941

subject_name: Antigens


subject: UMLS:C0808086

subject_name: Streptococcus pneumoniae group B Antigen


subject: UMLS:C0808084

subject_name: Streptococcus pneumoniae group A Antigen


subject: UMLS:C1545907

subject_name: A variant not otherwise specified Antigen


subject: CHEBI:2654

subject_name: Aminoglutethimide


subject: CHEBI:30512

subject_name: Silver


subject: CHEBI:73788

subject_name: Ala-Gln


subject: CHEBI:49468

subject_name: Silver cation


subject: CHEBI:40618

subject_name: Pimagedine


subject: PR:000004168

subject_name: amyloid-beta precursor protein


subject: UMLS:C0243192

subject_name: agonists


subject: CHEBI:24433

subject_name: group


subject: CHEBI:59549

subject_name: essential fatty acid

object_name: malnutrition


subject: MESH:D005228

subject_name: Fatty Acids, Essential


subject: CHEBI:22599

subject_name: arabinose


subject: CHEBI:15843

subject_name: Arachidonate


subject: PR:000003562

subject_name: ATP-binding cassette sub-family C member 6


subject: CHEBI:32551


subject: CHEBI:29967

subject_name: L-lysine residue


subject: CHEBI:133538

subject_name: Lysine


subject: UMLS:C0024337

subject_name: lysine


subject: UMLS:C0304475

subject_name: Potassium supplement


subject: CHEBI:29103


subject: CHEBI:26216

subject_name: potassium atom


subject: UMLS:C3714637

subject_name: Potassium Drug Class


subject: CHEBI:28659

subject_name: Phosphorus


subject: CHEBI:29035


subject: CHEBI:18291

subject_name: manganese atom


subject: CHEBI:83766

subject_name: Olaparib

object_name: Recurrent Triple-Negative Breast Carcinoma


subject: CHEBI:83766

object_name: Unresectable Primary Peritoneal Serous Adenocarcinoma


subject: CHEBI:83766

object_name: Refractory Triple-Negative Breast Carcinoma


subject: CHEBI:83766

object_name: Metastatic Primary Peritoneal Serous Adenocarcinoma


subject: CHEBI:83766

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: CHEBI:83766

object_name: Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma


subject: CHEBI:83766

object_name: Refractory Primary Peritoneal Serous Adenocarcinoma


subject: CHEBI:83766

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: CHEBI:83766

object_name: Unresectable Fallopian Tube High Grade Serous Adenocarcinoma


subject: CHEBI:83766

object_name: Refractory Fallopian Tube High Grade Serous Adenocarcinoma


subject: CHEBI:83766

object_name: Metastatic Fallopian Tube High Grade Serous Adenocarcinoma


subject: CHEBI:83766

object_name: Recurrent Fallopian Tube High Grade Serous Adenocarcinoma


subject: CHEBI:83766

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:83766

object_name: Refractory Ovarian Serous Adenocarcinoma


subject: CHEBI:140592

subject_name: Onalespib


subject: CHEBI:140592

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: CHEBI:140592


subject: CHEBI:140592


subject: CHEBI:140592

object_name: Breast cancer recurrent


subject: CHEBI:140592


subject: CHEBI:140592


subject: CHEBI:140592


subject: CHEBI:140592


subject: CHEBI:140592


subject: CHEBI:140592

object_name: Unresectable Malignant Solid Neoplasm


subject: CHEBI:140592


subject: CHEBI:140592


subject: CHEBI:140592


subject: CHEBI:140592


subject: CHEBI:140592

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:140592


subject: CHEBI:140592

object_name: Recurrent Ovarian High Grade Serous Adenocarcinoma


subject: CHEBI:140592


subject: CHEBI:94366

subject_name: itraconazole

object_name: Cachexia


subject: UMLS:C5555005

subject_name: Zelenectide Pevedotin

object_name: Metastatic urothelial carcinoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Oculocardiac Reflex


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:6121

subject_name: Ketamine


subject: UMLS:C5666953

subject_name: Anti-TIGIT/Anti-PD-L1 Bispecific Antibody HLX301

object_name: Neoplasm Metastasis


subject: UMLS:C5666953

object_name: adult lymphoma


subject: UMLS:C5666953

object_name: lymphoma


subject: UMLS:C5666953

object_name: pediatric lymphoma


subject: CHEBI:6801

subject_name: Metformin

object_name: arteriosclerosis disorder


subject: CHEBI:6801

object_name: atherosclerosis


subject: CHEBI:41139

subject_name: BETAINE

object_name: Overweight and obesity


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: mild cognitive impairment


subject: UMLS:C3529756

subject_name: bendavia

object_name: ST-elevation myocardial infarction


subject: UMLS:C3529756

object_name: ST Elevation Myocardial Infarction


subject: UMLS:C3489662

object_name: Reperfusion Injury


subject: UMLS:C3489662


subject: UMLS:C3489662


subject: CHEBI:63918

subject_name: Artesunate

object_name: Anal high grade squamous intraepithelial lesion


subject: CHEBI:63918

object_name: Anal Precancerous Condition


subject: CHEBI:63918

object_name: Anal intraepithelial neoplasia


subject: CHEBI:63918

object_name: human papilloma virus infection


subject: CHEBI:83766

object_name: inflammatory breast carcinoma


subject: CHEBI:83766

object_name: Locally Advanced Malignant Neoplasm


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: Inflammation


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C5433403

subject_name: Forxiga

object_name: glomerulonephritis


subject: CHEBI:85078

subject_name: Dapagliflozin


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: thrombocytopenia


subject: UNII:834YJF89WO

subject_name: Belumosudil

object_name: psoriasis vulgaris


subject: GTOPDB:12990

subject_name: sintilimab

object_name: carcinoma of esophagus


subject: GTOPDB:12990

object_name: esophageal cancer


subject: GTOPDB:12990

object_name: Childhood Esophageal Carcinoma


subject: GTOPDB:12990

object_name: neoplasm of esophagus


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UMLS:C2349988

subject_name: Myobacterium w (attenuated)

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: Stage IB Lung Cancer AJCC v7


subject: CHEBI:93786


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:404903

subject_name: Ertapenem

object_name: Bacteremia caused by Staphylococcus aureus


subject: CHEBI:404903

object_name: Staphylococcus aureus septicaemia


subject: CHEBI:404903

object_name: Staphylococcus aureus endocarditis


subject: CHEBI:404903

object_name: Staphylococcal bacteraemia


subject: UMLS:C4087034

subject_name: Spleen Tyrosine Kinase Inhibitor HMPL-523

object_name: rheumatoid arthritis


subject: UMLS:C2930158

subject_name: WITHANIA SOMNIFERA

object_name: amyotrophic lateral sclerosis


subject: GTOPDB:8323

subject_name: monalizumab

object_name: Microsatellite instability-high colorectal cancer


subject: GTOPDB:8323

object_name: Microsatellite Instability


subject: UNII:3ZXZ2V0588


subject: UNII:3ZXZ2V0588


subject: UMLS:C3896730


subject: UMLS:C3896730


subject: PUBCHEM.COMPOUND:4442

subject_name: Ramosetron

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:4442

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:4442

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:4442

object_name: Chemotherapy-induced nausea and vomiting


subject: UNII:G6UF363ECX

object_name: glioma


subject: UNII:G6UF363ECX

object_name: malignant glioma


subject: UNII:G6UF363ECX

object_name: diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype


subject: UNII:G6UF363ECX

object_name: Diffuse Midline Glioma, H3 K27-Altered


subject: UNII:G6UF363ECX

object_name: diffuse glioma, H3 G34 mutant


subject: UNII:G6UF363ECX

object_name: IDH-wildtype glioblastoma


subject: UMLS:C4308025

subject_name: AAA 617


subject: UMLS:C4308025


subject: UMLS:C4308025


subject: UMLS:C4308025


subject: UMLS:C4308025


subject: UMLS:C4308025


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:47808

subject_name: Sulforaphane

object_name: Parkinson disease


subject: UMLS:C4039583

subject_name: Chimeric antigen receptor

object_name: B-cell neoplasm


subject: UMLS:C4039583

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C0054946

subject_name: CD20 Antigens

object_name: non-Hodgkin lymphoma


subject: UMLS:C0054946


subject: PR:000001289

subject_name: membrane-spanning 4-domains subfamily A member 1


subject: PR:000001289


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: hepatitis B


subject: CHEBI:5931

subject_name: insulin human

object_name: Cognitive impairment


subject: UMLS:C4721874

subject_name: human insulin


subject: UMLS:C4721874

object_name: hypoglycemia


subject: UMLS:C4721874

object_name: Blood glucose below reference range (finding)


subject: UMLS:C4721874

object_name: Hypoglycemia, CTCAE


subject: UMLS:C0306371

subject_name: Humulin R


subject: UMLS:C0306371


subject: UMLS:C0306371


subject: UMLS:C0306371


subject: UMLS:C1707756

subject_name: Alcon

object_name: brain neoplasm


subject: GTOPDB:9297

subject_name: lutikizumab

object_name: ulcerative colitis


subject: GTOPDB:9297

object_name: inflammatory bowel disease 1


subject: CHEMBL.COMPOUND:CHEMBL4594518

subject_name: LUTIKIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4594518


subject: UMLS:C5226856


subject: UMLS:C5226856


subject: CHEBI:41001

subject_name: Benzoylecgonine

object_name: latent tuberculosis infection


subject: PUBCHEM.COMPOUND:251912

subject_name: Benzoyl ecgonine


subject: UMLS:C2698319

subject_name: Bacillus Calmette-Guerin Antigen


subject: PR:000002994

subject_name: natural resistance-associated macrophage protein 1


subject: UMLS:C0042210

subject_name: Vaccines

object_name: tuberculosis


subject: UMLS:C0042210


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UMLS:C3502707

object_name: hepatitis C


subject: UMLS:C0282100

subject_name: Paludrine

object_name: sickle cell disease


subject: CHEBI:27470

subject_name: Folic acid


subject: UMLS:C3827186

subject_name: Jobelyn


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Metastatic malignant neoplasm to pancreas


subject: UNII:GKF8S4C432

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: UNII:GKF8S4C432

object_name: pancreatic neoplasm


subject: UNII:GKF8S4C432

object_name: malignant pancreatic neoplasm


subject: GTOPDB:12989

subject_name: toripalimab


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:73272

subject_name: CANAGLIFLOZIN

object_name: diabetic kidney disease


subject: PUBCHEM.COMPOUND:74323022

subject_name: Canagliflozin


subject: CHEMBL.COMPOUND:CHEMBL2109323

object_name: neoplasm


subject: UMLS:C3273043


subject: CHEBI:135005

subject_name: Milnacipran

object_name: Idiopathic peripheral neuropathy


subject: CHEBI:17754

subject_name: Glycerin

object_name: Constipation


subject: CHEBI:17754

object_name: Constipation, CTCAE


subject: CHEBI:17634

subject_name: D-glucose

object_name: gestational diabetes


subject: CHEBI:91594

object_name: ovarian cancer


subject: CHEBI:91594

object_name: ovarian neoplasm


subject: UMLS:C0678133

subject_name: Taxol


subject: UMLS:C0678133


subject: UMLS:C0772411

subject_name: potato starch

object_name: Childhood Solid Neoplasm


subject: UMLS:C0772411

object_name: Adult Solid Neoplasm


subject: UMLS:C0772411

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Generalized chronic periodontitis


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C1541159

subject_name: CoFactor brand of 5,10-methylenetetrahydrofolate

object_name: Childhood Breast Carcinoma


subject: UMLS:C1541159

object_name: breast carcinoma


subject: UMLS:C1541159

object_name: breast cancer


subject: UMLS:C0178555

subject_name: chemical cofactor


subject: UMLS:C0178555


subject: UMLS:C0178555


subject: DRUGBANK:DB05308


subject: DRUGBANK:DB05308


subject: DRUGBANK:DB05308


subject: CHEBI:91414

subject_name: Adavosertib

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4053677


subject: CHEBI:31536

subject_name: Emtricitabine

object_name: Coronavinae infectious disease


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:7009

subject_name: Moxonidine

object_name: schizophrenia


subject: UMLS:C1579314

subject_name: Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed

object_name: tetanus


subject: UNII:TT3345YXVR

subject_name: Verdiperstat

object_name: multiple system atrophy


subject: CHEBI:63717

object_name: Weight Gain


subject: CHEBI:63717

object_name: Weight Gain, CTCAE


subject: CHEBI:63625


subject: CHEBI:63625


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: UniProtKB:P36394


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: PR:000015643


subject: CHEMBL.COMPOUND:CHEMBL2103793

subject_name: AGATOLIMOD SODIUM

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: Mantle cell lymphoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: Marginal zone lymphoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: nodal marginal zone B-cell lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: MALT lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: splenic marginal zone lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: Waldenstrom macroglobulinemia


subject: UNII:I4Z5C8FM6H


subject: UNII:I4Z5C8FM6H


subject: UNII:I4Z5C8FM6H


subject: UNII:I4Z5C8FM6H


subject: UNII:I4Z5C8FM6H


subject: UNII:I4Z5C8FM6H


subject: UNII:I4Z5C8FM6H


subject: UNII:I4Z5C8FM6H


subject: UNII:I4Z5C8FM6H


subject: UNII:I4Z5C8FM6H


subject: UNII:I4Z5C8FM6H


subject: UNII:I4Z5C8FM6H


subject: DRUGBANK:DB15018

subject_name: Agatolimod


subject: DRUGBANK:DB15018


subject: DRUGBANK:DB15018


subject: DRUGBANK:DB15018


subject: DRUGBANK:DB15018


subject: DRUGBANK:DB15018


subject: DRUGBANK:DB15018


subject: DRUGBANK:DB15018


subject: DRUGBANK:DB15018


subject: DRUGBANK:DB15018


subject: DRUGBANK:DB15018


subject: DRUGBANK:DB15018


subject: UMLS:C1831805

object_name: adult lymphoma


subject: UMLS:C1831805

object_name: lymphoma


subject: UMLS:C1831805

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: bipolar disorder


subject: PUBCHEM.COMPOUND:54675783

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:54675783

object_name: obesity


subject: PUBCHEM.COMPOUND:54675783

object_name: Obesity, CTCAE


subject: CHEBI:94708

subject_name: Diacerein

object_name: rheumatoid arthritis


subject: UMLS:C5706507

object_name: Alzheimer disease type 1


subject: UMLS:C5706507

object_name: Alzheimer disease


subject: CHEBI:144094

subject_name: bicalutamide

object_name: Recurrent Malignant Glioma


subject: CHEBI:144094

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:144094

object_name: Recurrent Glioblastoma


subject: UNII:WP6PY72ZH3

subject_name: Motolimod

object_name: Low grade B-cell lymphoma


subject: UNII:EKE8PS9J6Z

subject_name: Strontium chloride

object_name: osteoarthritis


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: bladder squamous cell carcinoma


subject: UNII:28X28X9OKV

object_name: bladder adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Bladder cancer stage IV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:25805

subject_name: oxygen atom

object_name: Premature infant


subject: CHEBI:25805

object_name: Premature birth


subject: CHEBI:25805

object_name: periventricular leukomalacia


subject: CHEBI:25805

object_name: Periventricular Leukomalacia, AE


subject: CHEBI:25805

object_name: Intraventricular hemorrhage


subject: CHEBI:25805

object_name: bronchopulmonary dysplasia


subject: CHEBI:25805

object_name: Bronchopulmonary Dysplasia, AE


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: CHEBI:15379


subject: CHEBI:15379


subject: CHEBI:15379


subject: CHEBI:15379


subject: CHEBI:15379


subject: GTOPDB:9296

subject_name: vunakizumab

object_name: small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298102

subject_name: VUNAKIZUMAB


subject: UMLS:C4726978

subject_name: Vunakizumab


subject: CHEBI:31824

subject_name: Mesna

object_name: ovarian cancer


subject: CHEBI:31824

object_name: ovarian neoplasm


subject: CHEBI:31824

object_name: ovarian carcinoma


subject: CHEBI:31824

object_name: Childhood Teratoma


subject: CHEBI:31824

object_name: adult teratoma


subject: CHEBI:31824

object_name: teratoma


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:9570

subject_name: Thiotepa

object_name: childhood germ cell tumor


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:3084

subject_name: Bethanechol

object_name: Tracheobronchomalacia


subject: UMLS:C1999216

subject_name: Inhibitor

object_name: acute coronary syndrome


subject: UMLS:C1999216

object_name: arteriosclerosis disorder


subject: UMLS:C1999216

object_name: atherosclerosis


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: stroke disorder


subject: UNII:PP0SHH6V16

object_name: cerebrovascular disorder


subject: UNII:PP0SHH6V16

object_name: Stroke (heart beat)


subject: UNII:PP0SHH6V16

object_name: Stroke, CTCAE


subject: CHEBI:139072

object_name: Phantom Limb


subject: CHEBI:139072

object_name: Phantom Limb Pain


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: UNII:G3QE979K1X

object_name: schizophrenia


subject: CHEBI:30830

subject_name: sodium oxybate

object_name: Parkinson disease


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: digestive system cancer


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:91398

subject_name: Tivantinib

object_name: Plasma cell myeloma refractory


subject: CHEBI:4856

subject_name: Esmolol

object_name: Sepsis


subject: CHEBI:4856

object_name: Sepsis, CTCAE


subject: CHEBI:16664

subject_name: Albendazole

object_name: protozoa infectious disease


subject: MESH:C000709231

object_name: hematopoietic and lymphoid cell neoplasm


subject: MESH:C000709231

object_name: hematopoietic and lymphoid system neoplasm


subject: MESH:C000709231

object_name: neoplasm


subject: CHEBI:23965

subject_name: estradiol

object_name: Gender Dysphoria


subject: CHEBI:23965

object_name: gender incongruence


subject: CHEBI:145372

subject_name: Gilteritinib

object_name: myelodysplastic syndrome with excess blasts-2


subject: UMLS:C0666155

subject_name: ABT 089

object_name: Alzheimer disease


subject: CHEMBL.COMPOUND:CHEMBL5314347

subject_name: SEVELAMER CARBONATE

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C0812987

subject_name: Chemotherapy Drugs Adminstered

object_name: Small cell lung cancer extensive stage


subject: UMLS:C3888312

object_name: metastatic colorectal cancer


subject: PUBCHEM.COMPOUND:135742497

subject_name: MEK inhibitor


subject: UMLS:C2347168

subject_name: Mitogen-Activated Protein Kinase Kinase Inhibitor


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: euthyroid Graves orbitopathy


subject: CHEBI:3160

object_name: endocrine exophthalmos


subject: UNII:X86Z1O656G

subject_name: xentuzumab

object_name: breast neoplasm


subject: UMLS:C3827152


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: Cervical spine instability


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:60791

subject_name: Xylocard


subject: CHEBI:60791

object_name: Post-Operative Pain


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:143658

object_name: retinoblastoma


subject: CHEBI:143658

object_name: retina neoplasm


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: head and neck neoplasm


subject: CHEBI:63607

subject_name: Linezolid

object_name: kidney disorder


subject: CHEBI:63607

object_name: impaired renal function disease


subject: PUBCHEM.COMPOUND:435949

subject_name: IV


subject: PUBCHEM.COMPOUND:435949


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: CHEBI:33313

subject_name: polonium atom


subject: CHEBI:33313


subject: CHEBI:7421

subject_name: NAC

object_name: tuberculosis


subject: CHEBI:3757

subject_name: Clonidine

object_name: Critical Illness


subject: CHEBI:125628

subject_name: Alisertib

object_name: peritoneum cancer


subject: CHEBI:125628

object_name: fallopian tube carcinoma


subject: CHEBI:125628

object_name: fallopian tube cancer


subject: CHEBI:63451

subject_name: Infigratinib

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:63451

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:63451

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:63451

object_name: cholangiocarcinoma


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: nasopharyngeal carcinoma


subject: UMLS:C0013227

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: CHEBI:132082

subject_name: Entinostat

object_name: kidney failure


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: neoplastic meningitis


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: CHEBI:135919

subject_name: Nesiritide

object_name: acute myocardial infarction


subject: CHEBI:135919

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:7936

subject_name: Paroxetine

object_name: mental disorder


subject: CHEBI:7936

object_name: psychiatric disorder


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril

object_name: Complication of peritoneal dialysis


subject: PUBCHEM.COMPOUND:54214995

object_name: Complication of hemodialysis


subject: CHEBI:9927

subject_name: Valsartan


subject: CHEBI:9927


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Burn injury


subject: CHEBI:89324

object_name: Burn, CTCAE


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: acquired idiopathic inflammatory myopathy


subject: CHEBI:71200

object_name: idiopathic inflammatory myopathy


subject: CHEMBL.COMPOUND:CHEMBL2108628

subject_name: PACLITAXEL POLIGLUMEX

object_name: squamous cell carcinoma


subject: CHEBI:46345

subject_name: Fluorouracil

object_name: common wart


subject: CHEBI:62880

subject_name: Veliparib

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C1831920

subject_name: ABT 888


subject: UMLS:C5552956

subject_name: Direct Oral Anticoagulant

object_name: acquired polycythemia vera


subject: UMLS:C5552956

object_name: essential thrombocythemia


subject: UMLS:C5552956

object_name: cellular phase chronic idiopathic myelofibrosis


subject: UMLS:C5552956


subject: UMLS:C3817338

subject_name: Cysview

object_name: bladder tumor


subject: UMLS:C3817338

object_name: urinary bladder carcinoma


subject: UMLS:C3817338

object_name: urinary bladder cancer


subject: UMLS:C3817338

object_name: childhood bladder carcinoma


subject: CHEBI:37845

subject_name: growth hormone

object_name: Phelan-McDermid syndrome


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: PR:000007968

subject_name: somatotropin


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Toxic effect of ethyl alcohol


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: postmenopausal atrophic vaginitis


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEBI:93775

subject_name: Amethopterin

object_name: malaria


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:35895

subject_name: tetraphosphorus

object_name: Imbalance of constituents of food intake


subject: UMLS:C1615057

subject_name: Phosphorus, homeopathic preparation


subject: CHEBI:28659

subject_name: Phosphorus


subject: UMLS:C3714498

subject_name: Phosphorus Drug Class


subject: CHEBI:64312

subject_name: Memantine

object_name: schizoaffective disorder


subject: CHEBI:64312

object_name: schizophrenia 18


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Atrophic acne scar


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: Neck Carcinoma


subject: UNII:P0GVQ9A4S5

object_name: head and neck neoplasm


subject: UNII:P0GVQ9A4S5

object_name: head and neck cancer


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UNII:1C6V77QF41

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:1C6V77QF41

object_name: peripheral T-cell lymphoma, not otherwise specified


subject: UNII:1C6V77QF41

object_name: Adult Primary Cutaneous Anaplastic Large Cell Lymphoma


subject: UNII:1C6V77QF41

object_name: primary cutaneous anaplastic large cell lymphoma


subject: UNII:1C6V77QF41

object_name: subcutaneous panniculitis-like T-cell lymphoma


subject: UNII:1C6V77QF41

object_name: primary mediastinal large B-cell lymphoma


subject: UNII:1C6V77QF41

object_name: Anaplastic large cell lymphoma T- and null-cell types refractory


subject: UNII:1C6V77QF41

object_name: extranodal nasal NK/T cell lymphoma


subject: UNII:1C6V77QF41

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: UNII:1C6V77QF41

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: UNII:1C6V77QF41

object_name: enteropathy-associated T-cell lymphoma


subject: UNII:1C6V77QF41

object_name: angioimmunoblastic T-cell lymphoma


subject: UNII:1C6V77QF41

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UNII:1C6V77QF41

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UNII:1C6V77QF41

object_name: anaplastic large cell lymphoma


subject: UNII:1C6V77QF41

object_name: Aggressive Non-Hodgkin Lymphoma


subject: UNII:1C6V77QF41

object_name: Aggressive Adult Non-Hodgkin Lymphoma


subject: UNII:1C6V77QF41

object_name: diffuse large B-cell lymphoma


subject: UNII:1C6V77QF41

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:1C6V77QF41

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:1C6V77QF41

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:27300

subject_name: Ergocalciferol

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:27300

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:27300

object_name: peripheral T-cell lymphoma, not otherwise specified


subject: CHEBI:27300

object_name: Adult Primary Cutaneous Anaplastic Large Cell Lymphoma


subject: CHEBI:27300

object_name: primary cutaneous anaplastic large cell lymphoma


subject: CHEBI:27300

object_name: subcutaneous panniculitis-like T-cell lymphoma


subject: CHEBI:27300

object_name: primary mediastinal large B-cell lymphoma


subject: CHEBI:27300

object_name: Anaplastic large cell lymphoma T- and null-cell types refractory


subject: CHEBI:27300

object_name: extranodal nasal NK/T cell lymphoma


subject: CHEBI:27300

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:27300

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:27300

object_name: enteropathy-associated T-cell lymphoma


subject: CHEBI:27300

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:27300

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:27300

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:27300

object_name: anaplastic large cell lymphoma


subject: CHEBI:27300

object_name: Aggressive Non-Hodgkin Lymphoma


subject: CHEBI:27300

object_name: Aggressive Adult Non-Hodgkin Lymphoma


subject: CHEBI:27300

object_name: diffuse large B-cell lymphoma


subject: CHEBI:27300

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:27300

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:27300

object_name: hepatosplenic T-cell lymphoma


subject: UMLS:C5554986

subject_name: CBP/p300 Bromodomain Inhibitor FT-7051

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:63630

subject_name: Tolcapone

object_name: nicotine dependence


subject: UMLS:C4732990

object_name: liver carcinoma


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: fallopian tube carcinoma


subject: UNII:K16AIQ8CTM

object_name: fallopian tube cancer


subject: UNII:K16AIQ8CTM

object_name: peritoneum cancer


subject: CHEBI:85993

subject_name: Palbociclib

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UMLS:C3896842

object_name: colorectal cancer


subject: UMLS:C3896842

object_name: colorectal carcinoma


subject: UMLS:C3896842

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3896842

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C3896842

object_name: Embolism, Tumor


subject: UMLS:C3896842

object_name: Neoplasm Metastasis


subject: UMLS:C3896842

object_name: Advanced cancer


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: PUBCHEM.COMPOUND:138566969

subject_name: Baloxavir marboxil

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:138566969

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C5707733

subject_name: Copper Cu 64 SAR-Bombesin

object_name: prostate cancer


subject: UMLS:C5707733

object_name: prostate neoplasm


subject: UMLS:C5855276

subject_name: Copper Cu 67 SAR-bombesin


subject: UMLS:C5855276


subject: UMLS:C0008586

subject_name: Chromogranins

object_name: Lumbar spine degeneration


subject: UMLS:C0008586

object_name: Neck Arthritis


subject: CHEBI:57986

object_name: hematologic disorder


subject: CHEBI:57986

object_name: oncologic disorders


subject: UMLS:C3714502

subject_name: Riboflavin Drug Class


subject: UMLS:C3714502


subject: CHEBI:17621

subject_name: FMN


subject: CHEBI:17621


subject: CHEBI:17015

subject_name: Riboflavin


subject: CHEBI:17015


subject: PUBCHEM.COMPOUND:11297617

subject_name: PEGAMOTECAN

object_name: sarcoma


subject: PUBCHEM.COMPOUND:11297617

object_name: soft tissue sarcoma


subject: UNII:ZY7ZTE7LFH


subject: UNII:ZY7ZTE7LFH


subject: CHEBI:176724

subject_name: Etiracetam

object_name: idiopathic generalized epilepsy


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: pediatric osteosarcoma


subject: CHEBI:233362

object_name: Osteosarcoma


subject: CHEBI:233362

object_name: bone chondrosarcoma


subject: CHEBI:233362

object_name: chondrosarcoma


subject: UMLS:C1337075

subject_name: Ortho-Cyclen

object_name: type 2 diabetes mellitus


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: scleroderma


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: UNII:I5590ES2QZ

subject_name: Fosbretabulin

object_name: neoplasm


subject: PUBCHEM.COMPOUND:24996163


subject: CHEBI:5134

subject_name: Fluticasone

object_name: Persistent asthma


subject: UNII:090IP5RV8F

subject_name: Omadacycline

object_name: pulmonary non-tuberculous mycobacterial infection


subject: UNII:090IP5RV8F

object_name: Nontuberculous mycobacterial pulmonary infection


subject: UNII:090IP5RV8F

object_name: Mycobacterium abscessus Infection


subject: UNII:090IP5RV8F


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: T-Cell Lymphoma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: UNII:QMS40680K6

subject_name: Palifermin


subject: CHEBI:125354

subject_name: Plerixafor


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: TRANSPLANTS AND IMPLANTS


subject: UMLS:C1709429


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Ocular surface disease


subject: CHEBI:41879

object_name: Ocular Surface Disease, CTCAE


subject: CHEBI:73678


subject: CHEBI:73678


subject: CHEBI:73678

object_name: dry eye syndrome


subject: CHEBI:28864

subject_name: Tobramycin


subject: CHEBI:28864


subject: CHEBI:28864


subject: CHEBI:71956

subject_name: retaspimycin hydrochloride

object_name: plasma cell myeloma


subject: UMLS:C1708447

subject_name: IPI 504


subject: CHEBI:4495

subject_name: Diazoxide

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:4495

object_name: obesity


subject: CHEBI:4495

object_name: Obesity, CTCAE


subject: CHEBI:4495

object_name: hyperinsulinism


subject: CHEBI:4495

object_name: Hyperinsulinemia


subject: CHEBI:16646

subject_name: carbohydrate

object_name: hereditary endocrine growth disease


subject: CHEBI:16646

object_name: Child Malnutrition


subject: MESH:D000073893

subject_name: Sugars


subject: MESH:D000073893


subject: UMLS:C3665462

subject_name: raw sugar


subject: UMLS:C3665462


subject: CHEBI:17992

subject_name: Sucrose


subject: CHEBI:17992


subject: CHEBI:6503

subject_name: LISINOPRIL

object_name: impaired renal function disease


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:49662

subject_name: Indomethacin

object_name: migraine


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate

object_name: lung cancer


subject: PUBCHEM.COMPOUND:16760419

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:16760419

object_name: lung carcinoma


subject: CHEBI:85990

subject_name: Panobinostat


subject: CHEBI:85990


subject: CHEBI:85990


subject: UMLS:C2347905

object_name: Neoplasm Metastasis


subject: UMLS:C2347905

object_name: cancer


subject: UMLS:C2347905

object_name: neoplasm


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: rectal carcinoma


subject: GTOPDB:9592

object_name: rectal cancer


subject: GTOPDB:9592

object_name: Childhood Rectal Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: pelvic organ prolapse, susceptibility to


subject: MESH:D012462

object_name: rectal prolapse


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: Locally Advanced Breast Carcinoma


subject: PUBCHEM.COMPOUND:6096882

object_name: inflammatory breast carcinoma


subject: PUBCHEM.COMPOUND:6096882

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UMLS:C5206815

object_name: pancreatic neoplasm


subject: UMLS:C5206815

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5206815

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: colon cancer liver metastasis


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:5847

subject_name: Raltitrexed


subject: UNII:9566855ULN

subject_name: ISOBUTAMBEN

object_name: Chronic uremia


subject: CHEBI:6759

subject_name: Mepivacaine


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:50749

subject_name: Calcipotriol

object_name: actinic keratosis


subject: CHEBI:68551

subject_name: Linaclotide

object_name: digestive system cancer


subject: CHEBI:68551

object_name: Heartburn


subject: CHEBI:68551

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: CHEBI:68551

object_name: Barrett esophagus


subject: UNII:7IK8Z952OK

subject_name: Plecanatide


subject: UNII:7IK8Z952OK


subject: UNII:7IK8Z952OK


subject: UNII:7IK8Z952OK


subject: UNII:5IB2J79MCX

subject_name: Spesolimab

object_name: generalized pustular psoriasis


subject: CHEBI:18361

object_name: systemic sclerosis


subject: CHEBI:18361

object_name: scleroderma


subject: MESH:D011756

subject_name: Diphosphates


subject: MESH:D011756


subject: CHEBI:29888

subject_name: Pyrophosphate


subject: CHEBI:29888


subject: MESH:C541363

object_name: ovarian cancer


subject: MESH:C541363

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:71080313

subject_name: Volasertib


subject: PUBCHEM.COMPOUND:71080313


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: primary central nervous system lymphoma


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: PR:000010755


subject: UMLS:C1831975

object_name: benign prostatic hyperplasia


subject: CHEBI:8988

object_name: Neoplasm of cecum and/or colon and/or rectum


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:74705

subject_name: Met-Leu

object_name: ectopic pregnancy


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:465284

subject_name: Ganciclovir


subject: CHEBI:465284

object_name: myeloproliferative neoplasm


subject: CHEBI:465284

object_name: Non-Cancer Diagnosis


subject: CHEBI:465284

object_name: Myelodysplasia


subject: CHEBI:465284

object_name: leukemia


subject: CHEBI:465284

object_name: childhood leukemia


subject: CHEBI:465284

object_name: adult lymphoma


subject: CHEBI:465284

object_name: lymphoma


subject: CHEBI:465284

object_name: pediatric lymphoma


subject: CHEBI:31401

subject_name: Cilostazol

object_name: intracerebral hemorrhage


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Dentofacial Deformities


subject: UNII:0WAX4UT396

subject_name: Razuprotafib

object_name: retinal vein occlusion


subject: UMLS:C4727210

subject_name: Cadonilimab

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C4727210

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:165632

subject_name: Dibutyl decanedioate

object_name: Fabry disease


subject: CHEBI:165632

object_name: end stage renal failure


subject: CHEBI:165632

object_name: Chronic uremia


subject: PR:000010238

subject_name: guanine nucleotide exchange factor DBS


subject: PR:000010238


subject: PR:000010238


subject: UniProtKB:Q64096

subject_name: MCF2L_MOUSE Guanine nucleotide exchange factor DBS (sprot)


subject: UniProtKB:Q64096


subject: UniProtKB:Q64096


subject: UniProtKB:P41416

subject_name: CXOL_NPVAC Conotoxin-like peptide (sprot)

object_name: melanoma


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: venous thromboembolism


subject: CHEBI:8768

object_name: thrombophilia due to thrombin defect


subject: CHEBI:8768

object_name: atrial fibrillation


subject: CHEBI:8768

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:8768

object_name: Atrial Fibrillation, CTCAE


subject: MESH:D012900

subject_name: Smallpox Vaccine

object_name: milker's nodule


subject: CHEMBL.COMPOUND:CHEMBL2108688

subject_name: SMALLPOX VACCINE


subject: UMLS:C2700141

subject_name: vaccinia virus strain New York City Board of Health live antigen


subject: UNII:35A26E427H

subject_name: Reslizumab

object_name: chronic rhinosinusitis


subject: UNII:35A26E427H

object_name: Nasal Polyp


subject: UMLS:C4760692

subject_name: Doxorubicin Hydrochloride for Injection

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C4760692

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C4760692

object_name: sarcoma


subject: UMLS:C4760692

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C4760692

object_name: soft tissue sarcoma


subject: UMLS:C4760692


subject: UMLS:C0879272

object_name: prostate neoplasm


subject: CHEBI:59204

subject_name: Carbetocin

object_name: high-risk pregnancy


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: Nodule of lung


subject: CHEMBL.COMPOUND:CHEMBL3545103

object_name: lung disorder


subject: UMLS:C0376607

subject_name: Anti-Obesity Agents

object_name: obesity due to congenital leptin deficiency


subject: UMLS:C0376607

object_name: obesity due to leptin receptor gene deficiency


subject: UMLS:C0376607

object_name: morbid obesity


subject: CHEMBL.COMPOUND:CHEMBL4594594

subject_name: ITEPEKIMAB

object_name: chronic rhinosinusitis without nasal polyps


subject: UMLS:C5421034

subject_name: itepekimab


subject: UMLS:C5565157


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: macular degeneration


subject: UNII:2S9ZZM9Q9V

object_name: retinitis pigmentosa 30


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Critical Illness


subject: UNII:PVI5M0M1GW

object_name: respiratory failure


subject: UNII:PVI5M0M1GW

object_name: acute respiratory failure


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PUBCHEM.COMPOUND:91820620

subject_name: Aviptadil Acetate

object_name: Dyspnea


subject: PUBCHEM.COMPOUND:91820620

object_name: Dyspnea, CTCAE


subject: PUBCHEM.COMPOUND:91820620

object_name: cardiovascular surgery result: dyspnea


subject: PUBCHEM.COMPOUND:91820620

object_name: Acute lung injury/Acute respiratory distress syndrome (ARDS)


subject: PUBCHEM.COMPOUND:91820620

object_name: acute respiratory distress syndrome


subject: PUBCHEM.COMPOUND:91820620

object_name: acute lung injury


subject: PUBCHEM.COMPOUND:91820620

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: PUBCHEM.COMPOUND:91820620

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: PUBCHEM.COMPOUND:91820620

object_name: adult acute respiratory distress syndrome


subject: UMLS:C5545169

subject_name: aviptadil acetate


subject: UMLS:C5545169


subject: UMLS:C5545169


subject: UMLS:C5545169


subject: UMLS:C5545169


subject: UMLS:C5545169


subject: UMLS:C5545169


subject: UMLS:C5545169


subject: UMLS:C5545169


subject: UMLS:C0964961

object_name: irritable bowel syndrome


subject: CHEBI:94771

subject_name: Quisinostat

object_name: ovarian cancer


subject: CHEBI:94771

object_name: ovarian neoplasm


subject: CHEBI:5050

subject_name: Fexofenadine

object_name: Uremic pruritus


subject: CHEBI:5050

object_name: Chronic kidney disease-associated pruritus


subject: CHEBI:5050

object_name: end stage renal failure


subject: CHEBI:5050

object_name: Chronic uremia


subject: CHEBI:5050

object_name: kidney failure


subject: CHEBI:15407

subject_name: Ephedrine

object_name: Blood Pressure Finding


subject: CHEBI:15407

object_name: Systemic arterial pressure


subject: GTOPDB:11485


subject: GTOPDB:11485


subject: GTOPDB:11485

object_name: ovarian carcinoma


subject: GTOPDB:11485

object_name: Solid Neoplasm


subject: UMLS:C5761781


subject: UMLS:C5761781


subject: UMLS:C5761781


subject: UMLS:C5761781


subject: UMLS:C0879624

object_name: prostate cancer


subject: UMLS:C0879624

object_name: prostate neoplasm


subject: CHEBI:9168

subject_name: Sirolimus

object_name: polycystic kidney disease 2


subject: UMLS:C0162713

subject_name: Photosensitizing Agents

object_name: Klatskin Tumor


subject: UMLS:C0873137

subject_name: Korean ginseng preparation

object_name: Decreased liver function


subject: DRUGBANK:DB01404

subject_name: Ginseng


subject: CHEBI:9168

object_name: immunoglobulin G4-related sclerosing disease


subject: CHEBI:9168

object_name: Immunoglobulin G4-Related Disease


subject: CHEBI:85078

subject_name: Dapagliflozin


subject: CHEBI:34574


subject: CHEBI:42085

subject_name: 7,8-Diamino-Nonanoic Acid


subject: CHEBI:16026

subject_name: 2,6-Diaminopimelic Acid


subject: CHEBI:2247

subject_name: 7,8-diaminononanoic acid


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Malignant Solid Neoplasm


subject: CHEBI:144551

subject_name: Oxybutynin

object_name: Physical trauma


subject: CHEBI:144551

object_name: Injury


subject: CHEBI:144551

object_name: Trauma


subject: CHEBI:50861

subject_name: Treprostinil

object_name: Reperfusion Injury


subject: CHEBI:50861

object_name: Delayed Graft Function


subject: CHEBI:134964

subject_name: Perflubutane

object_name: peripheral vascular disease


subject: CHEBI:134964

object_name: peripheral arterial disease


subject: MESH:C069727

subject_name: Sonazoid


subject: MESH:C069727


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: graft versus host disease


subject: PUBCHEM.COMPOUND:73005958

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:73005958

object_name: Recurrent disease


subject: PUBCHEM.COMPOUND:73005958

object_name: Global Relapse in Viscera


subject: PUBCHEM.COMPOUND:73005958

object_name: Global Relapse in Lymph Nodes


subject: PUBCHEM.COMPOUND:73005958

object_name: Relapse Following Intervention for Kawasaki Disease


subject: PUBCHEM.COMPOUND:73005958

object_name: Global Relapse


subject: PUBCHEM.COMPOUND:73005958

object_name: Global Relapse in Skin


subject: PUBCHEM.COMPOUND:73005958

object_name: Global Relapse in Blood


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: UMLS:C4764370

subject_name: Cudarolimab

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:135207

subject_name: Clofedanol


subject: CHEBI:135207

object_name: Pulmonary thrombosis


subject: CHEBI:15365

subject_name: Aspirin


subject: UMLS:C2826110

subject_name: onartuzumab

object_name: non-small cell lung carcinoma


subject: CHEBI:6504

object_name: medullary thyroid gland carcinoma


subject: UMLS:C1654726

subject_name: heme iron polypeptide

object_name: anemia


subject: UMLS:C1654726

object_name: Anemia, CTCAE


subject: UMLS:C1654726

object_name: kidney failure


subject: UMLS:C1654726

object_name: Renal Failure, CTCAE


subject: UMLS:C0938417

subject_name: Fe heme polypeptide


subject: UMLS:C0938417


subject: UMLS:C0938417


subject: UMLS:C0938417


subject: UMLS:C0021745

subject_name: interferon type II

object_name: COVID-19 respiratory infection


subject: UMLS:C0021745

object_name: Acute respiratory disease


subject: UMLS:C3539881

subject_name: gamma-interferon


subject: UMLS:C3539881


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: hemophagocytic syndrome


subject: UMLS:C3854325

subject_name: Janus kinase inhibitor

object_name: ulcerative colitis


subject: UMLS:C3854325

object_name: inflammatory bowel disease 1


subject: UMLS:C3854326

subject_name: Janus Kinase Inhibitor [EPC]


subject: UMLS:C3854326


subject: CHEBI:4026

object_name: chronic leukemia


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: Metastatic non-small cell lung cancer


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: CHEBI:231324

subject_name: alpelisib

object_name: Hepatic impairment


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Agitation, CTCAE 3.0


subject: CHEBI:36791

object_name: Agitation


subject: CHEBI:36791

object_name: Agitation, CTCAE 5.0


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: Meniere disease


subject: UMLS:C4305842

object_name: epilepsy


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: adult lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: pediatric lymphoma


subject: CHEBI:15544

subject_name: Alprostadil

object_name: stroke disorder


subject: CHEBI:15544

object_name: cerebrovascular disorder


subject: CHEBI:15544

object_name: Stroke (heart beat)


subject: CHEBI:15544

object_name: Stroke, CTCAE


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: endometrium adenocarcinoma


subject: UNII:68AYS9A614

object_name: endometrial clear cell adenocarcinoma


subject: UNII:68AYS9A614

object_name: endometrial serous adenocarcinoma


subject: UNII:68AYS9A614

object_name: endometrial adenosquamous carcinoma


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: PUBCHEM.COMPOUND:9296

subject_name: treosulfan

object_name: Acute myeloid leukemia in remission


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:9296

object_name: Neoplasm, Residual


subject: UMLS:C1882421

subject_name: defined green tea catechin extract

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:196462

subject_name: ketosteril

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:196462

object_name: Chronic Kidney Disease, CTCAE


subject: PUBCHEM.COMPOUND:196462

object_name: sarcopenia


subject: UMLS:C0064327


subject: UMLS:C0064327


subject: UMLS:C0064327


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Postmenopausal


subject: CHEBI:38290

object_name: Insulin resistance


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: CHEBI:8382

subject_name: Prednisone

object_name: long QT syndrome


subject: CHEBI:8382

object_name: familial long QT syndrome


subject: CHEBI:8382

object_name: Prolonged QT interval


subject: CHEBI:8382

object_name: connective tissue disorder


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Low back pain


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:123610

subject_name: Eptifibatide

object_name: angina unstable


subject: CHEBI:68558

subject_name: Ticagrelor


subject: CHEBI:233414

object_name: brain glioblastoma


subject: CHEBI:233414

object_name: Adult Brain Glioblastoma


subject: CHEBI:233414

object_name: Childhood Brain Glioblastoma


subject: CHEBI:233414

object_name: Recurrent Malignant Glioma


subject: MESH:C552724

subject_name: OKN 007


subject: MESH:C552724


subject: MESH:C552724


subject: MESH:C552724


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: UMLS:C3896909

object_name: Malignant neoplasm of the central nervous system


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: Papulopustular Rosacea


subject: GTOPDB:8323

subject_name: monalizumab

object_name: head and neck squamous cell carcinoma


subject: UNII:3ZXZ2V0588


subject: UMLS:C3896730


subject: CHEBI:6413

subject_name: Letrozole

object_name: ovarian cyst


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: graft versus host disease


subject: UMLS:C1832035


subject: CHEBI:29708

subject_name: Zinc gluconate

object_name: Prolonged neonatal jaundice


subject: CHEBI:33198

subject_name: Gluconic Acid


subject: PUBCHEM.COMPOUND:23664049

subject_name: SODIUM GLUCONATE


subject: PUBCHEM.COMPOUND:11154555

subject_name: Cariprazine

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:11154555

object_name: major depressive disorder


subject: CHEBI:90933


subject: CHEBI:90933


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: bipolar disorder


subject: CHEBI:76016

object_name: bipolar depression


subject: PUBCHEM.COMPOUND:6328211

subject_name: Alhydrogel

object_name: ancylostomiasis


subject: UMLS:C0733770


subject: CHEMBL.COMPOUND:CHEMBL5314986

subject_name: GLA-AF


subject: UNII:03J11K103C

subject_name: ALGELDRATE


subject: CHEBI:49662

subject_name: Indomethacin

object_name: colorectal neoplasm


subject: CHEBI:49662

object_name: neoplasm of esophagus


subject: CHEBI:49662

object_name: ovarian cancer


subject: CHEBI:49662

object_name: ovarian neoplasm


subject: CHEBI:8499

subject_name: Propranolol

object_name: prostate carcinoma


subject: CHEBI:6801

subject_name: Metformin

object_name: HIV-1 infection


subject: MESH:C573452

subject_name: Embryo glue

object_name: Embryo Loss


subject: MESH:C573452

object_name: paroxysmal familial ventricular fibrillation


subject: MESH:C573452

object_name: ventricular fibrillation, paroxysmal familial, type 1


subject: MESH:C573452

object_name: habitual spontaneous abortion


subject: MESH:C573452

object_name: pregnancy loss, recurrent, susceptibility to, 1


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: gingivitis


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: PR:000008924

subject_name: interferon beta 1

object_name: multiple sclerosis


subject: UMLS:C5417780

subject_name: KRT 232


subject: UMLS:C5417780

object_name: Post-polycythemia vera myelofibrosis


subject: MESH:C562184

object_name: actinic keratosis


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Sicca Syndrome


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:61080

subject_name: Romidepsin

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:61080

object_name: Mantle cell lymphoma recurrent


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Seizure Related to COVID-19


subject: PUBCHEM.COMPOUND:521372

object_name: visual epilepsy


subject: GTOPDB:13396

subject_name: ivonescimab

object_name: salivary gland carcinoma


subject: GTOPDB:13396

object_name: salivary gland cancer


subject: GTOPDB:13396

object_name: Salivary gland cancer stage IV


subject: GTOPDB:13396

object_name: Metastatic salivary gland cancer


subject: GTOPDB:13396

object_name: Advanced Salivary Gland Carcinoma


subject: GTOPDB:13396

object_name: adrenal cortex carcinoma


subject: GTOPDB:13396

object_name: adenoid cystic carcinoma


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: PUBCHEM.COMPOUND:137319706

subject_name: Orforglipron

object_name: osteoarthritis


subject: UNII:7ZW40D021M

subject_name: ORFORGLIPRON


subject: UMLS:C5565157

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:21881649

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:108065

subject_name: proanthocyanidin


subject: CHEBI:166895

subject_name: procyanidin


subject: UMLS:C1449695

subject_name: Procyanidins


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Knee pain


subject: UMLS:C4507512

object_name: diabetic macular edema


subject: UMLS:C5963387

subject_name: Anti-TAA Monoclonal Antibody-chelator Conjugate BAY3547922

object_name: Solid Neoplasm


subject: UMLS:C5963386

subject_name: Zirconium Zr 89 Anti-TAA Monoclonal Antibody BAY3630942


subject: UMLS:C5963386

object_name: liver carcinoma


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: colon carcinoma


subject: MESH:C079198

object_name: colon cancer


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: glaucoma


subject: CHEBI:31300

object_name: Glaucoma, CTCAE


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:51450


subject: UMLS:C0282090

subject_name: Laxatives

object_name: Bowel incontinence


subject: UMLS:C0282090

object_name: Fecal Incontinence, CTCAE


subject: UMLS:C0718565

subject_name: Anti-Diarrheal


subject: UMLS:C0718565


subject: UMLS:C1871141

subject_name: TMI 005

object_name: rheumatoid arthritis


subject: CHEBI:44241

subject_name: Metyrapone

object_name: endocrine system disorder


subject: CHEBI:29033

subject_name: Ferrous cation


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: cardiac allograft vasculopathy


subject: CHEBI:231342

subject_name: ceralasertib

object_name: melanoma


subject: CHEBI:63610

subject_name: Misoprostol


subject: UniProtKB:P53767

subject_name: VGFR1_RAT Vascular endothelial growth factor receptor 1 (sprot)

object_name: age-related macular degeneration


subject: PR:000007563

subject_name: vascular endothelial growth factor receptor 1


subject: PR:000002112

subject_name: vascular endothelial growth factor receptor 2


subject: CHEBI:64019

subject_name: Nebivolol

object_name: essential hypertension


subject: DRUGBANK:DB17107

subject_name: Lifileucel

object_name: Metastatic non-small cell lung cancer


subject: PUBCHEM.COMPOUND:152165

object_name: Pain, Procedural


subject: PUBCHEM.COMPOUND:152165

object_name: Pain following procedure


subject: PUBCHEM.COMPOUND:152165

object_name: Post-Procedural Pain


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:75722


subject: CHEBI:75722


subject: UMLS:C5435429


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Severe Aplastic Anemia


subject: CHEBI:66919

object_name: severe aplastic anemia


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: tuberculosis


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: PR:000050337

subject_name: mature calcitonin


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: CHEMBL.COMPOUND:CHEMBL3545013

object_name: schizophrenia


subject: CHEBI:31413

subject_name: Clobazam

object_name: Lennox-Gastaut syndrome


subject: CHEBI:7025

subject_name: Mupirocin

object_name: Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site


subject: UMLS:C1831798

object_name: post operative nausea and vomiting


subject: UMLS:C5854608

subject_name: Hpk1 Inhibitor GRC 54276

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5854608

object_name: adult lymphoma


subject: UMLS:C5854608

object_name: lymphoma


subject: UMLS:C5854608

object_name: pediatric lymphoma


subject: CHEBI:17688

subject_name: Nicotine

object_name: Cigarette Smoking-Related Carcinoma


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch


subject: CHEBI:145371

subject_name: Binimetinib

object_name: Metastatic Mucosal Melanoma


subject: CHEBI:145371

object_name: acral lentiginous melanoma


subject: CHEBI:145371

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:145371

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: UNII:8L7891MRB6

subject_name: Encorafenib


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C1608615

object_name: chronic obstructive pulmonary disease


subject: UMLS:C1608615

object_name: pneumococcal infection


subject: UMLS:C1608615

object_name: asthma


subject: CHEBI:3286

subject_name: Cabergoline

object_name: endometriosis


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: myeloproliferative neoplasm


subject: CHEBI:28939

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:28939

object_name: essential thrombocythemia


subject: CHEBI:28939

object_name: myelofibrosis


subject: CHEBI:28939

object_name: acquired polycythemia vera


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:45716

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:45716

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C3896707

subject_name: Telomelysin


subject: DRUGBANK:DB18672

subject_name: Suratadenoturev


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: fetal growth restriction


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB

object_name: Advanced Urothelial Carcinoma


subject: UNII:DLE8519RWM

object_name: Unresectable Urothelial Carcinoma


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:149837

subject_name: Alisporivir


subject: UMLS:C1567950

subject_name: alisporivir


subject: CHEBI:36791

subject_name: Escitalopram

object_name: bipolar depression


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Childhood Acute Myeloid Leukemia in Remission


subject: CHEBI:9168

object_name: Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A


subject: CHEBI:9168

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:9168

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: CHEBI:9168

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:9168

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:9168

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: CHEBI:9168

object_name: Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:9168

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:9168

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:9168

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:9168

object_name: Blast Phase


subject: CHEBI:9168

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:9168

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:9168


subject: CHEBI:9168

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:9168

object_name: Childhood Acute Lymphoblastic Leukemia in Remission


subject: CHEBI:9168

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:9168

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:9168

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:9168

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:9168

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:9168

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:9168

object_name: Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma


subject: CHEBI:9168

object_name: Stage II Contiguous Adult Diffuse Large Cell Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: CHEBI:9168

object_name: Stage II Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:9168

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:9168

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:9168

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:9168

object_name: Childhood Immunoblastic Lymphoma


subject: CHEBI:9168

object_name: Stage III Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:9168

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:9168

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:9168

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:9168

object_name: Stage IV Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:9168

object_name: Stage I Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:9168

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: CHEBI:9168

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:9168

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:9168

object_name: Stage I Adult Immunoblastic Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: CHEBI:9168

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:9168

object_name: Stage III Childhood Large Cell Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma


subject: CHEBI:9168

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:9168

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma


subject: CHEBI:9168

object_name: Stage I Adult Diffuse Large Cell Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: CHEBI:9168

object_name: Recurrent Childhood Large Cell Lymphoma


subject: CHEBI:9168

object_name: Stage IV Childhood Large Cell Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: CHEBI:9168

object_name: Stage I Childhood Large Cell Lymphoma


subject: CHEBI:9168

object_name: Childhood Diffuse Large Cell Lymphoma


subject: CHEBI:9168

object_name: Stage II Childhood Lymphoblastic Lymphoma


subject: CHEBI:9168

object_name: Mantle cell lymphoma stage III


subject: CHEBI:9168

object_name: B-cell small lymphocytic lymphoma stage II


subject: CHEBI:9168

object_name: Stage III Childhood Lymphoblastic Lymphoma


subject: CHEBI:9168

object_name: Stage II Childhood Burkitt Lymphoma


subject: CHEBI:9168

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:9168

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:9168

object_name: Stage IV Childhood Lymphoblastic Lymphoma


subject: CHEBI:9168

object_name: Mantle cell lymphoma stage I


subject: CHEBI:9168

object_name: Stage I Childhood Lymphoblastic Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:9168

object_name: Stage III Childhood Burkitt Lymphoma


subject: CHEBI:9168

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:9168

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:9168

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:9168

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:9168

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:9168

object_name: Recurrent Childhood Burkitt Lymphoma


subject: CHEBI:9168

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:9168

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:9168

object_name: Stage IV Childhood Burkitt Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:9168

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage I Grade 3 Follicular Lymphoma


subject: CHEBI:9168

object_name: Stage I Childhood Burkitt Lymphoma


subject: CHEBI:9168

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: CHEBI:9168

object_name: Stage I Adult Lymphoblastic Lymphoma


subject: CHEBI:9168

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:9168

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:9168

object_name: Marginal zone lymphoma stage III


subject: CHEBI:9168

object_name: B-cell small lymphocytic lymphoma stage I


subject: CHEBI:9168

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:9168

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:9168

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:9168

object_name: Marginal zone lymphoma stage I


subject: CHEBI:9168

object_name: Stage I Adult Burkitt Lymphoma


subject: CHEBI:9168

object_name: Burkitt lymphoma


subject: CHEBI:9168

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:9984

subject_name: vincaleukoblastine sulfate

object_name: malignant soft tissue neoplasm


subject: CHEBI:9984

object_name: sarcoma


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: CHEBI:9241

subject_name: Spironolactone

object_name: proteinuria


subject: CHEBI:9241

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:9241

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:9241

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:9241

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C0723422

subject_name: Spironol


subject: UMLS:C0723422


subject: UMLS:C0723422


subject: UMLS:C0723422


subject: UMLS:C0723422

object_name: chronic kidney disease


subject: UMLS:C0723422


subject: CHEBI:52763


subject: CHEBI:52763


subject: CHEBI:52763


subject: CHEBI:52763


subject: CHEBI:52763


subject: CHEBI:52763


subject: CHEBI:37845

subject_name: growth hormone

object_name: atherosclerosis


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: UNII:NQX9KB6PCL


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: PR:000007968

subject_name: somatotropin


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:131769963

object_name: chronic myelomonocytic leukemia


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Metastatic osteosarcoma


subject: UNII:52CMI0WC3Y

object_name: Osteosarcoma recurrent


subject: UNII:52CMI0WC3Y

object_name: Unresectable Osteosarcoma


subject: UNII:52CMI0WC3Y

object_name: Refractory Osteosarcoma


subject: UNII:52CMI0WC3Y

object_name: Locally Advanced Osteosarcoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:72317

subject_name: Cabozantinib


subject: CHEBI:15407

subject_name: Ephedrine

object_name: Pregnant


subject: CHEBI:8093

subject_name: Phenylephrine


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Radiation necrosis


subject: UNII:2S9ZZM9Q9V

object_name: Effects of radiation


subject: UNII:2S9ZZM9Q9V

object_name: Radiation Sickness


subject: UMLS:C5237721

subject_name: FAK1 Inhibitor IN10018

object_name: non-small cell lung carcinoma


subject: UMLS:C4305796

object_name: COPD, severe early onset


subject: UMLS:C4305796

object_name: chronic obstructive pulmonary disease


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)


subject: UniProtKB:P19726


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stage III Uterine Corpus Cancer AJCC v6


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:90227

subject_name: Selumetinib

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:90227

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:90227

object_name: Stage IV Childhood Non-Hodgkin Lymphoma


subject: CHEBI:90227

object_name: Stage III Childhood Non-Hodgkin Lymphoma


subject: CHEBI:90227

object_name: Refractory Neuroblastoma


subject: CHEBI:90227

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:90227

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:90227

object_name: Refractory Primary Central Nervous System Neoplasm


subject: CHEBI:90227

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:90227

object_name: Recurrent Childhood Central Nervous System Neoplasm


subject: CHEBI:90227

object_name: Neuroblastoma recurrent


subject: UNII:807ME4B7IJ

subject_name: SELUMETINIB SULFATE


subject: UNII:807ME4B7IJ


subject: UNII:807ME4B7IJ


subject: UNII:807ME4B7IJ


subject: UNII:807ME4B7IJ


subject: UNII:807ME4B7IJ


subject: UNII:807ME4B7IJ


subject: UNII:807ME4B7IJ


subject: UNII:807ME4B7IJ


subject: UNII:807ME4B7IJ


subject: UNII:807ME4B7IJ


subject: UNII:4685R51V7M

subject_name: Esmirtazapine

object_name: vasomotor symptom


subject: UNII:4685R51V7M

object_name: Menopause present (finding)


subject: UNII:4685R51V7M

object_name: Menopause


subject: CHEBI:6950

subject_name: Mirtazapine


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Contraceptive device complication


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: Hyperhidrosis


subject: CHEBI:4636

object_name: Atopic rhinitis


subject: CHEBI:4636

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:4636

object_name: Diphenhydramine causing adverse effects in therapeutic use


subject: CHEBI:4636

object_name: Hyperthermia


subject: CHEBI:4636

object_name: Fever